15 Stocks Moving In Thursday's After-Hours Session

Gainers

Amazon AMZN shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above estimates.

Western Digital WDC shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 EPS and sales guidance above estimates.

Atlassian TEAM shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 sales guidance above estimates.

Fortinet FTNT shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.

EHealth EHTH shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.

Five9 FIVN shares are trading higher after the company reported better-than-expected Q1 EPS and sales results and raised FY21 EPS and sales guidance above estimates.

Digital Turbine APPS shares are trading higher after the company issued Q4 and FY21 sales guidance above estimates.

Losers

Twitter TWTR shares are trading lower after the company reported Q1 earnings results.

Gilead Sciences GILD shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results and issued FY21 EPS guidance below estimates.

Skyworks Solutions SWKS shares are trading lower after the company reported Q2 earnings and issued Q3 guidance.

DexCom DXCM shares are trading lower after the company reported Q1 earnings results.

Cirrus Logic CRUS shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.

Microvision MVIS shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.

Limelight Networks LLNW shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.

Ardelyx ARDX shares are trading lower after the company announced the PDUFA date for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis has been extended by three months.